Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting NCT03299569

Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland

Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland — Recruiting • Cardiology / Cardiovascular • NCT03299569.

📅 09 Sep 2026 ⏱ 1 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
NCT ID
NCT03299569
Sponsor
University of Aberdeen
Start
2016-07-29
ClinicaliQ Trial Snapshot
  • Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland — Recruiting • Cardiology / Cardiovascular • NCT03299569.
  • Sponsor: University of Aberdeen.

Verify eligibility, endpoints and current status on the original source registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

Acute stress-induced (Takotsubo cardiomyopathy) presents like a heart attack and is triggered by intense emotional or physical stress. Although coronary arteries are unobstructed, it has been suggested that the risk of death is similar to a myocardial infarction. The purpose of the STARR study is to identify all cases of Takotsubo in Scotland since 2010 and assess its epidemiology and outcomes.

Eligibility Snapshot
  • : * All patients diagnosed with Takotsubo cardiomyopathy

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Guideline
Aficamten for treating symptomatic obstructive hypertrophic cardiomyopathy
Cardiology / Cardiovascular · 30 Jul 2026
Patient selection: Consider aficamten for symptomatic obstructive hypertrophic cardiomyopathy patients who remain symptomatic despite optimised standard therapy (beta-blockers, non-dihydropyridine calcium channel blockers,…
View guideline →
Clinical Brief
Meet the teenagers calling for action on violence against women and girls
Cardiology / Cardiovascular · BBC Health · 28 Jul 2026
Teenage activists are mobilising public engagement on violence against women and girls (VAWG), highlighting widespread concern among younger generations about this health…
View brief →
Clinical Brief
The ‘heartbreaking’ OCD that can make you doubt your relationship
Cardiology / Cardiovascular · BBC Health · 16 Jul 2026
Relationship OCD is an underrecognised condition characterised by intrusive doubts about romantic partnerships, requiring greater clinical awareness for timely diagnosis and intervention…
View brief →
Clinical Brief
Heat exhaustion or heatstroke: Can you tell the difference?
Cardiology / Cardiovascular · BBC Health · 10 Jul 2026
Heat Exhaustion vs Heatstroke: Clinical Summary Heat exhaustion presents with heavy sweating, dizziness, nausea and rapid pulse due to dehydration and electrolyte…
View brief →
Clinical Brief
What in the World
Cardiology / Cardiovascular · BBC Health · 07 Jul 2026
Heatwaves pose significant clinical risk, with heatstroke and dehydration representing the primary acute complications requiring recognition and management Healthcare professionals should anticipate…
View brief →
Guideline
Artificial intelligence (AI)-assisted echocardiography analysis and reporting to support the diagnosis and monitoring of heart failure: early-use assessment
Cardiology / Cardiovascular · 19 May 2026
AI-assisted echocardiography can support faster preliminary analysis and reporting of echo images in heart failure patients, potentially reducing reporting delays and improving…
View guideline →